We are live on ! Find out more
CM

Corvex Management Portfolio holdings

AUM $2.52B
1-Year Est. Return 25.53%
This Fund
S&P 500
This Quarter Est. Return
-1.2%
1 Year Est. Return
+25.53%
3 Year Est. Return
+64.15%
5 Year Est. Return
+76.52%
10 Year Est. Return
+305.53%
AUM
$8.29B
AUM Growth
-$135M
Cap. Flow
-$41.9M
Cap. Flow %
-0.51%
Top 10 Hldgs %
70.15%
Holding
64
New
20
Increased
9
Reduced
12
Closed
17

Top Buys

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$127M
2
APC
Anadarko Petroleum
APC
+$125M
3
DHR icon
Danaher
DHR
+$119M
4
BUD icon
AB InBev
BUD
+$95.7M
5
AGN
Allergan Inc
AGN
+$71.6M

Sector Composition

Rank Sector Weight
1 Energy 28.55%
2 Financials 10.35%
3 Consumer Discretionary 7.8%
4 Healthcare 7.64%
5 Real Estate 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYX icon
26
NCR Voyix
VYX
$1.05B
$52M 0.63%
2,538,555
NSM
27
CALL
DELISTED
Nationstar Mortgage Holdings
NSM
$51.4M 0.62%
1,500,000
-750,000
-33% -$24.9M
CAG icon
28
Conagra Brands
CAG
$6.88B
$51.1M 0.62%
+1,987,323
New +$49M
AGN
29
CALL
DELISTED
Allergan plc
AGN
$48.3M 0.58%
200,000
AMAT icon
30
Applied Materials
AMAT
$447B
$44.4M 0.54%
+2,054,429
New +$45.5M
EMC
31
DELISTED
EMC CORPORATION
EMC
$43M 0.52%
+1,470,000
New +$42.4M
HUM icon
32
Humana
HUM
$47.4B
$35.9M 0.43%
+275,406
New +$35M
SBAC icon
33
SBA Communications
SBAC
$18.5B
$33.1M 0.4%
298,693
-401,307
-57% -$43.4M
FNFV
34
DELISTED
Fidelity Natl Financial, Inc.
FNFV
$32.9M 0.4%
+3,134,473
New +$37.4M
SLXP
35
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$28.1M 0.34%
+180,000
New +$26.1M
SPY icon
36
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$24.5M 0.3%
+124,500
New +$24.6M
RVBD
37
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$23M 0.28%
+1,239,802
New +$23.3M
EVTC icon
38
Evertec
EVTC
$1.79B
$21.1M 0.25%
943,000
-301,601
-24% -$6.89M
MCD icon
39
McDonald's
MCD
$187B
$19M 0.23%
+200,000
New +$19.1M
TAP icon
40
Molson Coors Class B
TAP
$7.51B
$13.4M 0.16%
+180,000
New +$13.1M
LADR
41
Ladder Capital
LADR
$1.22B
$5.45M 0.07%
+359,507
New +$5.33M
CLVS
42
DELISTED
Clovis Oncology, Inc.
CLVS
$4.25M 0.05%
+93,586
New +$3.91M
CCI.PRA
43
DELISTED
Crown Castle International Corp.
CCI.PRA
$3.67M 0.04%
35,000
DHR icon
44
CALL
Danaher
DHR
$135B
$3.65M 0.04%
71,416
-3,796,947
-98% -$195M
VVUS
45
DELISTED
Vivus Inc
VVUS
$3.51M 0.04%
90,997
-274
-0.3% -$12.2K
AZN icon
46
CALL
AstraZeneca
AZN
$261B
$1.47M 0.02%
+20,600
New +$1.51M
ARIA
47
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$540K 0.01%
100,000
APD icon
48
Air Products & Chemicals
APD
$65.5B
-216,200
Closed -$25.7M
AZN icon
49
AstraZeneca
AZN
$261B
-1,238,000
Closed -$90.6M
ESI icon
50
Element Solutions
ESI
$9.33B
-525,000
Closed -$14.7M

Similar funds

Corvex Management's Q3 2014 Portfolio in Review

As of Q3 2014, Corvex Management held 64 positions worth $8.29B, down 1.6% from $8.43B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Corvex Management's Q3 2014 filing shows 20 new, 9 increased, 12 reduced and 17 closed positions. Its largest new stake was Danaher: 2,321,018 shares worth $119M. The largest sale was Walgreens Boots Alliance, an estimated $127M.

By sector, the portfolio is most concentrated in Energy at 29% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corvex Management's largest Q3 2014 buy was Danaher: 2,321,018 shares worth $119M.
  • Corvex Management added most to Time Warner Inc in Q3 2014, an estimated $127M increase.
  • Corvex Management's biggest Q3 2014 reduction was Paramount Global Class B, cutting an estimated $85M.
  • Corvex Management fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $127M.
  • Corvex Management's ten largest holdings make up 70% of its $8.29B portfolio in Q3 2014.
  • Corvex Management opened 20 new positions and closed 17 in Q3 2014.
  • Corvex Management's portfolio value fell 1.6% quarter-over-quarter to $8.29B.

Based on Corvex Management's 13F filing for Q3 2014, filed 14 Nov 2014.